GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Research & Development

ACI Formulations (DHA:ACIFORMULA) Research & Development : BDT0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is ACI Formulations Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. ACI Formulations's Research & Development for the three months ended in Dec. 2023 was BDT0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was BDT0 Mil.

ACI Formulations Research & Development Historical Data

The historical data trend for ACI Formulations's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACI Formulations Research & Development Chart

ACI Formulations Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ACI Formulations Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ACI Formulations Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ACI Formulations  (DHA:ACIFORMULA) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ACI Formulations Research & Development Related Terms

Thank you for viewing the detailed overview of ACI Formulations's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

ACI Formulations (DHA:ACIFORMULA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » ACI Formulations Ltd (DHA:ACIFORMULA) » Definitions » Research & Development
Comparable Companies
WAR:EXM WAR:MAD WAR:EDL WAR:BTK WAR:O2T WAR:IFA CTVA TSX:NTR SAU:2020 CF SZSE:000792 MOS MIC:PHOR OSL:YAR MIC:AKRN FMC ADX:FERTIGLB XTAE:ICL NSE:PIIND BOM:590024
Traded in Other Exchanges
N/A
Address
ACI Centre, 245, Tejgaon Industrial Area, Dhaka, BGD, 1208
Website
https://www.aci-bd.com
ACI Formulations Ltd is an agricultural chemicals manufacturer. The principal activities of the company are manufacturing and marketing a number of agrochemical and consumer products. The company has structured its operations into the following business segments - Crop Care and Public Health segment, which manufactures and sell crop care and public health products; Mosquito Coil segment is engaged in the manufacturing and selling of mosquito coil products; the Aerosol segment is engaged in the manufacturing and selling aerosol and air freshener products; and Paint segment which manufactures and sells paint products. It derives key revenue from the Crop Care and Public Health segment.

ACI Formulations (DHA:ACIFORMULA) Headlines

No Headlines